Stockreport

Hikma Pharmaceuticals H2 Earnings Call Highlights [Yahoo! Finance]

HIKMA PHARMS PLC S/ADR  (HKMPY) 
NASDAQ:AMEX Investor Relations: hikma.com/en/investors.html
PDF performance, and set expectations for 2026 as management pivots toward increased investment—particularly in Injectables—while aiming to sustain group profitability and r [Read more]